ISEE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (11 Jul 2023 @ 04:00):

IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs)...

Stats
今日成交量	10.80M
平均成交量	4.95M
市值	5.51B
EPS	$-0.520 ( Q1 \| 2023-05-10 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-22.44 (Sector) 42.63 (Industry) 24.32
ATR14	$0.517 (1.29%)

AADI -3.24%

ABCL 1.83%

ABCM 0.04%

ABEO -2.14%

ABIO -1.68%

ABOS 0.70%

ABSI 1.70%

ABUS -1.64%

ABVX -1.50%

ACAD -0.58%

ACER -17.95%

ACET -5.08%

ACGN 1.29%

ACHL -4.11%

ACHV -0.22%

ACIU -0.75%

ACLX 0.95%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.16%

ADGI 0.87%

ADIL 1.75%

ADMA -2.09%

ADPT 0.00%

ADTX -2.08%

ADVM -3.33%

ADXN -1.60%

AEON -4.50%

AEZS -2.49%

AFMD -1.60%

AGEN -2.02%

AGIO -2.25%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.02%

AKRO -3.28%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.69%

ALGS -0.74%

ALKS 0.48%

ALLK -9.79%

ALLO -6.04%

ALLR -0.96%

ALNA 3.16%

ALNY 2.53%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.12%

ALVR 2.98%

ALXN 0.00%

ALXO -13.09%

ALZN 5.27%

AMRN -1.13%

AMTI -3.13%

ANAB 1.09%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.11%

ANPC -3.15%

APGE -0.72%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.32%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.02%

ARDS -14.23%

ARDX 0.29%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.16%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.91%

ARWR -1.06%

ASLN -3.88%

ASMB -5.81%

ASND -1.55%

ATAI -1.85%

ATHA 5.39%

ATHE 0.56%

ATHX -33.50%

ATNF 4.32%

ATOS 2.42%

ATRA -1.93%

ATXI -2.78%

ATXS -0.11%

AUPH -0.81%

AURA 2.79%

AUTL -1.29%

AVBP -3.32%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.48%

AVTX -1.25%

AVXL -3.70%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 3.66%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.41%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.95%

BDRX -4.64%

BDTX -1.81%

BEAM 1.03%

BFRA -2.91%

BGNE -2.44%

BIOR -6.15%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.33%

BMEA -10.71%

BMRN 0.15%

BNOX 6.22%

BNTC -0.42%

BNTX -1.62%

BOLD -12.19%

BOLT -1.24%

BPMC -0.85%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 25.75%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.87%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.20%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.67%

CCCC -5.21%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -7.72%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.20%

CDXS 7.24%

CELC -3.94%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.21%

CERO -3.88%

CEROW -21.56%

CFRX -27.95%

CGEM -2.92%

CGEN -3.31%

CGON -1.69%

CGTX -3.98%

CHMA -6.00%

CHRS 1.27%

CINC 0.00%

CING -0.63%

CINGW 34.95%

CKPT -3.81%

CLBS -16.75%

CLDX -1.02%

CLGN 0.34%

CLLS -4.15%

CLNN 2.43%

CLNNW 0.00%

CLRB 6.30%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.62%

CNST 0.00%

CNTA -0.45%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.12%

CORT 2.78%

COYA -1.46%

CPRX -1.02%

CRBP -3.43%

CRBU -5.98%

CRDF -0.89%

CRGX -0.13%

CRIS -1.72%

CRNX -5.64%

CRSP 0.63%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -3.73%

CTNM -2.11%

CTXR 2.76%

CUE 6.57%

CVAC -5.23%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.26%

CYTO -1.83%

DARE 4.02%

DAWN -1.04%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.71%

DNLI -1.39%

DNTH -10.31%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.51%

EDSA 3.19%

EFTR 5.89%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -5.81%

ELOX -5.38%

ELTX -4.26%

ELVN -4.07%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.72%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -2.42%

ETON 1.82%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.32%

EXEL 0.09%

EYEG -0.69%

EYEN 1.42%

EYPT 0.61%

FATE -9.95%

FBIO 0.85%

FBIOP -0.37%

FBLG -14.69%

FBRX -0.02%

FDMT -3.50%

FENC -0.97%

FGEN -7.27%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.93%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.22%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.53%

GHRS -2.30%

GLMD -5.09%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -3.14%

GLYC -10.15%

GMAB -0.23%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX 1.33%

GNPX 0.00%

GNTA 3.94%

GOSS -10.61%

GOVX 0.91%

GOVXW -49.04%

GPCR -8.73%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.18%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.47%

HALO -1.07%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 2.33%

HOTH -3.51%

HOWL -2.14%

HRMY 2.06%

HRTX 3.93%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 19.15%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.61%

IFRX -1.54%

IGMS -0.29%

IKNA 0.89%

IKT 0.70%

IMAB 2.03%

IMCR -2.96%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -7.76%

IMNM 0.87%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.75%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.76%

INAB -0.56%

INBX 0.76%

INCY -1.27%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.14%

INMB 1.68%

INO -1.30%

INSM -1.26%

INTS -2.75%

INVA 0.53%

INZY 0.69%

IOBT -10.67%

IONS 0.75%

IOVA -2.96%

IPA -0.49%

IPHA 5.58%

IPSC -2.34%

IRON -1.64%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.90%

JAGX 0.79%

JANX -3.70%

JAZZ -0.47%

JNCE 0.00%

JSPR -6.17%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -4.71%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.31%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.22%

KTRA 8.13%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -3.18%

KYTX -4.13%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.18%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -4.83%

LEXX 0.78%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.71%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.72%

LQDA -0.16%

LRMR -1.56%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -2.06%

LYEL -36.03%

LYRA 1.16%

MACK 0.10%

MBIO -10.02%

MBRX -1.72%

MCRB 3.17%

MDGL -0.88%

MDNA -13.16%

MDWD -0.34%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.34%

MGTA -7.74%

MGTX -3.57%

MGX -4.01%

MIRM -1.00%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.71%

MLYS -7.52%

MNKD 0.29%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.40%

MREO -2.57%

MRKR 2.57%

MRNA -5.90%

MRNS -4.04%

MRSN -2.14%

MRTX -0.17%

MRUS 0.21%

MRVI -1.16%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.46%

NAMS 3.33%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.59%

NKGN 10.14%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.54%

NLSP 5.35%

NLSPW 26.67%

NMRA -3.14%

NMTR -42.97%

NOVN -24.84%

NRBO 9.47%

NRIX -2.14%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.75%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -6.92%

NTRBW -31.07%

NUVL -1.69%

NVAX -2.50%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.45%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 2.54%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.12%

OMER -1.03%

OMGA 5.42%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.55%

ORMP 18.22%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.28%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.52%

PCSA 0.00%

PCVX -0.23%

PDSB -4.27%

PEPG 0.78%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -0.83%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.33%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.61%

PRAX 3.06%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.37%

PRQR -0.66%

PRTA -2.26%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.45%

PSTX -1.36%

PTCT -0.18%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 1.14%

QLGN -3.00%

QNCX 5.70%

QNRX -1.34%

QSI -11.59%

QSIAW -3.13%

QTTB -3.45%

QURE -0.79%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.27%

RCKT -8.51%

REGN 0.17%

RENB -3.41%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.78%

RGNX -5.56%

RIGL -3.29%

RLAY -3.85%

RLMD 0.35%

RLYB -1.01%

RNA 0.49%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -1.94%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.26%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -30.00%

RVNC 0.21%

RVPH -2.38%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.80%

RYTM -5.19%

RYZB 0.02%

RZLT 3.93%

SABS -1.37%

SABSW -11.81%

SAGE 1.19%

SANA -3.41%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.30%

SCPS 0.00%

SEEL -4.12%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.30%

SGMT -2.18%

SGTX -2.56%

SIOX 22.63%

SLDB -9.31%

SLGL 4.12%

SLN -4.57%

SLNO -4.44%

SLRX 5.26%

SLS -1.71%

SMMT -1.75%

SNDX 1.33%

SNGX -4.91%

SNPX -4.44%

SONN -0.01%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -0.90%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -5.66%

STRO -3.85%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -7.63%

SWTX -0.39%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.45%

TBPH 0.60%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.19%

TENX 1.91%

TERN -8.13%

TFFP -5.33%

TGTX -4.22%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.08%

TNXP -6.00%

TNYA -4.74%

TPST 5.11%

TRDA -4.06%

TRVI 2.30%

TRVN 3.88%

TSHA -22.31%

TSVT -2.93%

TTNP -7.66%

TVTX 1.13%

TYRA -8.54%

UBX -2.48%

UNCY -4.00%

URGN -1.15%

UTHR 0.61%

VACC 11.36%

VALN -4.07%

VAXX 100.00%

VBIV 0.33%

VBLT -8.77%

VCEL 0.74%

VCNX 10.35%

VCYT -1.34%

VERA -3.92%

VERU 0.98%

VERV -2.87%

VIGL 4.84%

VINC 2.28%

VIR 0.98%

VIRI -1.85%

VIRX 3.15%

VKTX -1.13%

VLON -13.04%

VNDA -3.50%

VOR -2.41%

VRCA -0.28%

VRDN -4.31%

VRNA -0.80%

VRPX 0.38%

VRTX 0.32%

VSTM -0.85%

VTGN -0.45%

VTVT -2.97%

VTYX -1.05%

VXRT -4.38%

VYGR 0.00%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.19%

XBIO 1.03%

XBIT -2.92%

XCUR 3.55%

XENE -1.36%

XERS 2.62%

XFOR 4.69%

XLO 3.94%

XLRN 0.00%

XNCR 0.62%

XOMA -2.85%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.65%

ZNTL -2.14%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-07-11	Blumenkranz Mark S.	Sell	32 088	Common Stock
2023-07-11	Blumenkranz Mark S.	Sell	7 500	Restricted Stock Units
2023-07-11	Blumenkranz Mark S.	Sell	31 000	Stock Option (Right to Buy)
2023-07-11	Blumenkranz Mark S.	Sell	15 500	Stock Option (Right to Buy)
2023-07-11	Blumenkranz Mark S.	Sell	23 186	Stock Option (Right to Buy)

INSIDER POWER
-97.77
Last 100 transactions
Buy: 73 584 \| Sell: 6 010 653

音量相关性

長: 0.24 (neutral)

短: 0.88 (strong)

Signal:(69.054) Same movement expected

Iveric Bio Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Iveric Bio Inc 相关性 - 货币/商品

0.53
( weak )

0.20
( neutral )

0.73
( moderate )

0.45
( neutral )

0.09
( neutral )

-0.86
( strong negative )

Iveric Bio Inc 财务报表

Annual	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-1.450

FY	2022
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$-1.450

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.120

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.140

Financial Reports:

No articles found.

Iveric Bio Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Iveric Bio Inc

IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). It also develops STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of leber congenital amaurosis type 10 (LCA10) and autosomal recessive stargardt disease (STGD1); IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases; IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa; and IC-200 for the treatment of IRDs associated with mutations in the BEST1 gene. In addition, the company develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of Zimura monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of Zimura administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. Its discovery and research programs include miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related IRDs. The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc. in April 2019. The company was incorporated in 2007 and is based in Parsippany, New Jersey.